Oculus confirms Microcyn against H1N1
Oculus Innovative Sciences (Petaluma, California), a healthcare company that makes products based upon the Microcyn Technology platform, which includes new formulations intended to reduce the use of antibiotics by preventing or treating infections including those caused by bacteria and viruses, has confirmed the effectiveness of Microcyn Technology at inactivating the H1N1 Swine Influenza A.
In a virucidal time-kill suspension test conducted by an independent laboratory, the Microcyn formulation reduced infectivity of the swine flu virus by 4.00 log10 (99.99%) reduction after just 30 seconds exposure.
More than 70 countries are reporting cases of human infection with H1N1 flu. This number has been increasing over the past few weeks, but many of the cases reportedly had links to travel or were localized outbreaks without community spread.
Biopure could face Nasdaq delisting
Biopure (Cambridge, Massachusetts) said that it has received notice from The Nasdaq Stock Market that it is out of compliance with the Nasdaq Marketplace Rules and its common stock may be delisted. The notice claimed that the company no longer meets the minimum of $2. 5 million in stockholders' equity for continued listing on the Nasdaq Capital Market.
Bopure makes pharmaceuticals, called oxygen therapeutics, that are intravenously administered to deliver oxygen to the body's tissues. The company has limited remaining cash. It is exploring the potential sale of some, substantially all, or all of its assets, and is evaluating liquidation.
KCM Holding plans registrations in 2010
KCM Holdings (Frisco, Texas) reported that it aims to complete three public registrations in 2009 and early 2010, after profitably weathering the worst economy in decades. KCM registrations are part of its incubation of companies in the healthcare, technology and alternative investment sectors.
KCM focuses its operations on the incubation of companies with little to no debt and have the ability to go to scale quickly across multiple sectors. KCM's first two registrations will be:
• CT Dental America (www.ctdentalgroup.com), a dental products, prosthetics, dental education and lifestyle member organization, projecting revenues of $120 million by its 4th year of operations.
• Geenius (www.geenius.com), a Web 3.0 company that has developed a social networking platform combined with a powerful user created content revenue model, and backed by a patented knowledge transfer technology. Geenius projects annual revenues of $300 million within five years.
The third registration will be in the Alternative Investment sector, with more details to be released soon.
Bausch & Lomb launches new patient center
Bausch & Lomb (Rochester, New York) reported the launch of the Center for Patient Insights – a first-of-its-kind initiative that strives to increase access to unbiased industry information, trends, market research, and insights for eye care professionals across the U.S. The Center for Patient Insights' main goal is to deliver news and insights that help eye care professionals better understand their patients, their industry and the information and opportunities available to them.